Cheng-Yuan Peng Selected Research

Hepatocellular Carcinoma (Hepatoma)

4/2024	Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
3/2024	Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals.
1/2024	Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
1/2024	Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
11/2023	Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion.
11/2023	Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.
1/2023	Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.
1/2023	Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
1/2023	Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.
1/2023	Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheng-Yuan Peng Research Topics

Disease

54	Chronic Hepatitis B 03/2024 - 01/2009
51	Fibrosis (Cirrhosis) 04/2024 - 02/2006
49	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2002
47	Chronic Hepatitis C 04/2024 - 07/2007
41	Infections 05/2024 - 07/2007
15	Neoplasms (Cancer) 04/2024 - 03/2002
12	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 08/2012
11	Hepatitis C 03/2024 - 03/2014
11	Virus Diseases (Viral Diseases) 04/2023 - 01/2006
9	Hepatitis B 11/2023 - 01/2006
7	Diabetes Mellitus 04/2024 - 01/2020
7	Liver Diseases (Liver Disease) 04/2024 - 07/2012
6	Liver Neoplasms (Liver Cancer) 04/2024 - 12/2016
5	Hemorrhage 07/2020 - 02/2006
4	Chronic Renal Insufficiency 02/2022 - 07/2020
4	Disease Progression 01/2022 - 01/2011
3	Reinfection 08/2022 - 01/2022
3	Inflammation (Inflammations) 06/2017 - 02/2009
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2024
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2022
2	Fatty Liver 01/2024 - 12/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2023
2	Obesity 10/2023 - 01/2023
2	Jaundice (Icterus) 12/2021 - 12/2008
2	Viremia 12/2021 - 03/2013
2	Ascites 12/2021 - 01/2019
2	Necrosis 11/2021 - 01/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2021
2	Medically Unexplained Symptoms 01/2019 - 06/2017
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 01/2016
2	Cholecystitis 01/2019 - 06/2013
2	Cytopenia 05/2016 - 05/2009
1	Communicable Diseases (Infectious Diseases) 01/2024

Drug/Important Bio-Agent (IBA)

54	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2008
32	entecavir FDA Link 01/2024 - 01/2009
30	InterferonsIBA 01/2022 - 07/2007
25	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 06/2008
19	Hepatitis B e AntigensIBA 03/2024 - 01/2009
15	Tenofovir (Viread)FDA Link 01/2024 - 08/2012
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 02/2015
10	SofosbuvirIBA 01/2024 - 01/2016
9	BilirubinIBA 04/2023 - 05/2016
8	daclatasvirIBA 01/2021 - 11/2014
8	Interferon-alpha (Interferon Alfa)IBA 02/2020 - 02/2009
7	asunaprevirIBA 01/2021 - 11/2014
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2018
6	velpatasvirIBA 01/2024 - 12/2018
6	AlbuminsIBA 01/2023 - 01/2020
6	Fetal Proteins (Fetoprotein)IBA 01/2023 - 01/2017
5	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
5	Alanine Transaminase (SGPT)IBA 04/2024 - 11/2011
5	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 04/2016
5	grazoprevirIBA 07/2023 - 11/2016
5	elbasvirIBA 07/2023 - 11/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 01/2020
4	sofosbuvir drug combination ledipasvirIBA 08/2022 - 07/2016
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 03/2015
3	Opioid Analgesics (Opioids)IBA 07/2023 - 11/2016
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
3	NucleotidesIBA 06/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 01/2015
3	adefovirIBA 07/2018 - 01/2009
3	Telbivudine FDA Link 03/2016 - 01/2014
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 02/2015
2	tenofovir alafenamideIBA 10/2023 - 06/2018
2	Carrier Proteins (Binding Protein)IBA 10/2022 - 04/2020
2	Transaminases (Aminotransferases)IBA 12/2021 - 05/2009
2	NivolumabIBA 11/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2009
2	Ritonavir (Norvir)FDA Link 12/2018 - 08/2018
2	Arachidonic Acid (Vitamin F)IBA 06/2017 - 03/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2017 - 03/2010
2	CytokinesIBA 06/2017 - 02/2009
2	Eicosapentaenoic AcidIBA 06/2017 - 03/2010
2	TabletsIBA 01/2017 - 07/2016
2	CollagenIBA 08/2016 - 01/2015
2	NucleosidesIBA 06/2016 - 01/2009
2	phosphomannopentaose sulfateIBA 08/2014 - 05/2009
2	Indicators and Reagents (Reagents)IBA 01/2014 - 08/2012
2	Lamivudine (Epivir)FDA Link 01/2014 - 12/2010
1	A-factor (Streptomyces)IBA 01/2024
1	LipidsIBA 10/2023

Therapy/Procedure

80	Therapeutics 04/2024 - 07/2007
4	Aftercare (After-Treatment) 08/2022 - 07/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2011
3	Liver Transplantation 01/2019 - 12/2008
3	Radiofrequency Ablation 01/2018 - 05/2002
2	Organ Transplantation 07/2020 - 01/2019
2	Duration of Therapy 06/2020 - 01/2017
2	Surgical Instruments (Clip) 01/2020 - 12/2016
2	Radiotherapy 01/2018 - 12/2016
2	Cholecystectomy 06/2013 - 02/2007
2	Plasma Exchange 10/2011 - 12/2008
2	Ligation 05/2010 - 02/2006